Surface-expressed invariant chain (CD74) is required for internalization of human leucocyte antigen-DR molecules to early endosomal compartments

Immunology

Volumn 96, Issue 3, 1999, Pages 473-484

  Moldenhauer, G ^a   Henne, C ^b   Karhausen, J ^c   Moller P ^c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; GAMMA INTERFERON; GUANOSINE TRIPHOSPHATASE; HLA DR ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN M; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; RAB PROTEIN; RECOMBINANT GAMMA INTERFERON;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; CELLULAR DISTRIBUTION; ENDOSOME; FLOW CYTOMETRY; HLA SYSTEM; IMMUNOFLUORESCENCE MICROSCOPY; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENDOCYTOSIS; ENDOSOMES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; INTERFERON-GAMMA, RECOMBINANT; MICROSCOPY, FLUORESCENCE; TUMOR CELLS, CULTURED;

EID: 0033019591     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00676.x     Document Type: Article

References (55)

1. NORDENG T.W. & BAKKE O. (1994) The biological role of invariant chain (Ii) in MHC class II antigen presentation. Immunol Lett 43, 47.
2. CRESSWELL P. (1994) Assembly, transport and function of MHC class II molecules. Annu Rev Immunol 12, 259.
3. KVIST S., WIMAN K., CLAESSON L., PETERSON P.A. & DOBBERSTEIN B. (1982) Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens. Cell 29, 61.
4. BAKKE O. & DOBBERSTEIN B. (1990) MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63, 707.
5. LOTTEAU V., TEYTON L., PELERAUX A. et al. (1990) Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348, 600.
6. LAMB C.A., YEWDELL J.W., BENNINK J.R. & CRESSWELL P. (1991) Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus. Proc Natl Acad Sci USA 88, 5998.
7. MOTTA A., BREMNES B., MORELLI M.A., FRANK R.W., SAVIANO G. & BAKKE O. (1995) Structure activity relationship of the leucine-based sorting motifs in the cytosolic tail of the major histocompatibility complex-associated invariant chain. J Biol Chem 270, 27165.
8. LANZAVECCHIA A. (1996) Mechanisms of antigen uptake for presentation. Curr Opin Immunol 8, 348.
9. BLUM J.S. & CRESSWELL P. (1988) Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc Natl Acad Sci USA 85, 3975.
10. MARIC M.A., TAYLOR M.D. & BLUM J.S. (1994) Endosomal aspartic proteinases are required for invariant chain processing. Proc Natl Acad Sci USA 91, 2171.
11. WRAIGHT C.J., VAN ENDERT P., MÖLLER P. et al. (1990) Human major histocompatibility complex class II invariant chain is expressed on the cell surface. J Biol Chem 265, 5787.
12. KOCH N., MOLDENHAUER G., HOFMANN W.J. & MÖLLER P. (1991) Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74). J Immunol 147, 2643.
13. ROCHE P.A., TELETSKI C.L., STANG E., BAKKE O. & LONG E.O. (1993) Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc Natl Acad Sci USA 90, 8581.
14. WARMERDAM P.A.M., LONG E.O. & ROCHE P.A. (1996) Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments. J Cell Biol 133, 281.
15. CRESSWELL P. (1985) Intracellular class II HLA antigens are accessible to transferrin-neuraminidase conjugates internalized by receptor-mediated endocytosis. Proc Natl Acad Sci USA 82, 8188.
16. GUAGLIARDI L.E., KOPPELMAN B., BLUM J.S., MARKS M.S., CRESSWELL P. & BRODSKY F.M. (1990) Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature 343, 133.
17. ROMAGNOLI P., LAYET C., YEWDELL J., BAKKE O. & GERMAIN R.N. (1993) Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments. J Exp Med 177, 583.
18. MA C. & BLUM J.S. (1997) Receptor-mediated endocytosis of antigens overcomes the requirement for HLA-DM in class II-restricted antigen presentation. J Immunol 158, 1.
19. CASTELLINO F. & GERMAIN R.N. (1995) Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity 2, 73.
20. KLEIJMEER M.J., MORKOWSKI S., GRIFFITH J.M., RUDENSKY A.Y. & GEUZE H.J. (1997) Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. J Cell Biol 139, 639.
21. SERCARCZ E.E., LEHMANN P.V., AMETANI A., BENICHOU G., MILLER A. & MOUDGIL K. (1993) Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 11, 729.
22. ZHONG G., ROMAGNOLI P. & GERMAIN R.N. (1997) Related leucine-based cytoplasmic targeting signals in invariant chain and major histocompatibility complex class II molecules control endocytic presentation of distinct determinants in a single protein. J Exp Med 185, 429.
23. GRIFFIN J.P., CHU R. & HARDING C.V. (1997) Early endosomes and a late endocytic compartment generate different peptide class II MHC complexes via distinct processing mechanisms. J Immunol 158, 1523.
24. BREMNES B., MADSEN T., GEDDE-DAHL M. & BAKKE O. (1994) An LI and ML motif in the cytoplasmic tail of the MHC-associated invariant chain mediate rapid internalization. J Cell Sci 107, 2021.
25. ODORIZZI G. & TROWBRIDGE I.S. (1997) Structural requirements for major histocompatibility complex class II invariant chain trafficking in polarized Madin-Darby canine kidney cells. J Biol Chem 272, 11757.
26. SIMONSEN A., STANG E., BREMNES B., ROE M., PRYDZ K. & BAKKE O. (1997) Sorting of MHC class II molecules and the associated invariant chain (Ii) in polarized MDCK cells. J Cell Sci 110, 597.
27. PINET V., VERGELLI M., MARTIN R., BAKKE O. & LONG E.O. (1995) Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 375, 603.
28. MÖLLER P., HENNE C. & MOLDENHAUER G. (1995) CD74 workshop panel report. In: Leucocyte Typing V: White Cell Differentiation Antigens (eds S. F. Schlossman, L. Boumsell, W. Gilks et al.), Vol 1, p. 568. Oxford University Press, Oxford.
29. QUARANTA V., MAJDIC O., STINGL G., LISZKA K., HONIGSMANN H. & KNAPP W. (1984) A human Ia cytoplasmic determinant located on multiple forms of invariant chain (′, ′2, ′3). J Immunol 132, 1900.
30. SHACKELFORD D.A., LAMPSON L.A. & STROMINGER J.L. (1981) Analysis of HLA-DR antigens by using monoclonal antibodies: recognition of conformational differences in biosynthetic intermediates. J Immunol 127, 1403.
31. GUY K., VAN HEYNINGEN V., COHEN B.B., DEANE D.L. & STEEL C.M. (1982) Differential expression and serologically distinct subpopulations of human Ia antigens detected with monoclonal antibodies to Ia alpha and beta chains. Eur J Immunol 12, 942.
32. ADAMS T.E., BODMER J.G. & BODMER W.F. (1983) Production and characterization of monoclonal antibodies recognizing the α-chain subunits of human Ia alloantigens. Immunology 50, 613.
33. BARNSTABLE C.J., BODMER W.F., BROWN G. et al. (1978) Production of monoclonal antibodies to group A erythrocytes, HLA and other human surface antigens new tools for genetic analysis. Cell 14, 9.
34. GODING J.W. (1980) Structural studies of murine lymphocyte surface IgD. J Immunol 124, 2082.
35. PETER M., HELLBRANDT S., SCHWARTZ-ALBIEZ R. et al. (1995) Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated cell death. Cell Death Diff 2, 163.
36. SOLLID L.M., GAUDERNACK G., MARKUSSEN G., KVALE D., BRANDTZAEG P. & THORSBY E. (1987) Induction of various HLA class II molecules in a human colonic adenocarcinoma cell line. Scand J Immunol 25, 175.
37. NEEFJES J.J., STOLLORZ V., PETERS P.J., GEUZE H.J. & PLOEGH H.L. (1990) The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 61, 171.
38. DEMOTZ S. (1993) DR αβ dimers released from complexes with invariant chain fail to stimulate alloreactive T cell clones. Eur J Immunol 23, 2100.
39. BIJLMAKERS M.J.E., BENAROCH P. & PLOEGH H.L. (1994) Assembly of HLA-DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain. EMBO J 13, 2699.
40. HEUSER J.E. & ANDERSON R.G. (1989) Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J Cell Biol 108, 389.
41. CHAVRIER P., PARTON R.G., HAURI H.P., SIMONS K. & ZERIAL M. (1990) Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments. Cell 62, 317.
42. ROCHE P.A. & CRESSWELL P. (1990) Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345, 615.
43. TEYTON L., O'SULLIVAN D., DICKSON P.W. et al. (1990) Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 348, 39.
44. ERICSON M.L., SUNDSTRÖM M., SANSOM D.M. & CHARRON D.J. (1994) Mutually exclusive binding of peptide and invariant chain to major histocompatibility complex class II antigens. J Biol Chem 269, 26531.
45. DAVIS J.E. & CRESSWELL P. (1990) Lack of detectable endocytosis of B lymphocyte MHC class II antigens using an antibody-independent technique. J Immunol 144, 990.
46. REID P.A. & WATTS C. (1992) Constitutive endocytosis of major histocompatibility complex class II glycoproteins in human B-lymphoblastoid cells. Immunology 77, 539.
47. BENAROCH P., YILLA M., RAPOSO G. et al. (1995) How MHC class II molecules reach the endocytic pathway. EMBO J 14, 3749.
48. WANG K., PETERSON P.A. & KARLSSON L. (1997) Decreased endosomal delivery of major histocompatibility complex class II-invariant chain complexes in dynamin-deficient cells. J Biol Chem 272, 17055.
49. VERGELLI M., PINET V., VOGT A.B. et al. (1997) HLA-DR-restricted presentation of purified myelin basic protein is independent of intracellular processing. Eur J Immunol 27, 941.
50. LANZAVECCHIA A., REID P.A. & WATTS C. (1992) Irreversible association of peptides with class II molecules in living cells. Nature 357, 249.
51. ADORINI L., APPELLA E., DORIA G., CARDINAUX F. & NAGY Z.A. (1989) Competition for antigen presentation in living cells involves exchange of peptides bound by class II MHC molecules. Nature 342, 800.
52. REAY P.A., WETTSTEIN D.A. & DAVIS M.M. (1992) pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule. EMBO J 11, 2829.
53. KROPSHOFER H., VOGT A.B. & HÄMMERLING G.J. (1995) Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding. Proc Natl Acad Sci USA 92, 8313.
54. KROPSHOFER H., VOGT A.B., STERN L.J. & HÄMMERLING G.J. (1995) Self release of CLIP in peptide loading of HLA-DR molecules. Science 270, 1357.
55. GERMAIN R.N. & HENDRIX L.R. (1991) MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353, 134.